Eveleth D D, Bradshaw R A
Department of Biological Chemistry, California College of Medicine, University of California, Irvine 92717.
Neuron. 1988 Dec;1(10):929-36. doi: 10.1016/0896-6273(88)90150-x.
The effects of agents that inhibit receptor-mediated endocytosis on type I (slow or high-affinity) and type II (fast or low-affinity) NGF binding have been examined in rat PC12 cells. Compounds interfering with endocytosis eliminate type I NGF binding; those interfering with acidification of endosomal vesicles cause increased type I binding at the expense of type II binding. Measurement of NGF binding during and after treatment with inhibitors indicates that NGF receptors rapidly cycle from the cell surface into an undefined endocytotic compartment and back to the surface with little degradation of receptor or NGF, consistent with a model in which NGF receptors are rapidly and reversibly endocytosed or sequestered; those receptors free on the surface represent type II NGF receptors, while those in the process of endocytosis represent type I NGF receptors. The type I and type II NGF receptor species can be interconverted by agents that can manipulate the position of the receptor in the internalization cycle.
在大鼠嗜铬细胞瘤(PC12)细胞中,研究了抑制受体介导的内吞作用的试剂对I型(慢或高亲和力)和II型(快或低亲和力)神经生长因子(NGF)结合的影响。干扰内吞作用的化合物会消除I型NGF结合;那些干扰内体小泡酸化的化合物会导致I型结合增加,代价是II型结合减少。在用抑制剂处理期间和之后测量NGF结合表明,NGF受体迅速从细胞表面循环到一个未定义的内吞区室,然后回到表面,受体或NGF几乎没有降解,这与NGF受体迅速且可逆地被内吞或隔离的模型一致;那些在表面游离的受体代表II型NGF受体,而那些处于内吞过程中的受体代表I型NGF受体。I型和II型NGF受体种类可以通过能够操纵受体在内化循环中位置的试剂相互转化。